Cargando…

Plasma resistant atypical hemolytic uremic syndrome associated with a CFH mutation treated with eculizumab: a case report

INTRODUCTION: Thrombotic microangiopathies are a group of diseases presenting as microangiopathic hemolytic anemia, thrombocytopenia and end-organ dysfunction. As the role of the complement system was elucidated in atypical hemolytic uremic syndrome pathogenesis, eculizumab was successfully introduc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sevinc, Mustafa, Basturk, Taner, Sahutoglu, Tuncay, Sakaci, Tamer, Koc, Yener, Ahbap, Elbis, Akgol, Cuneyt, Kara, Ekrem, Brocklebank, Vicky, Goodship, Tim HJ, Kavanagh, David, Unsal, Abdulkadir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423495/ https://www.ncbi.nlm.nih.gov/pubmed/25925370 http://dx.doi.org/10.1186/s13256-015-0575-y

Ejemplares similares

Can eculizumab be discontinued in aHUS?: Case report and review of the literature
por: Sahutoglu, Tuncay, et al.
Publicado: (2016)

Serum VEGF-C levels as a candidate biomarker of hypervolemia in chronic kidney disease
por: Sahutoglu, Tuncay, et al.
Publicado: (2017)

The relationship between serum albumin levels and 24-h ambulatory blood pressure monitoring recordings in non-diabetic essential hypertensive patients
por: Ahbap, Elbis, et al.
Publicado: (2016)

Outcome of 121 patients with renal amyloid a amyloidosis
por: Ahbap, Elbis, et al.
Publicado: (2014)

Clinical outcomes and mortality in elderly peritoneal dialysis patients
por: Sakacı, Tamer, et al.
Publicado: (2015)

The effects of angiotensin-converting enzyme inhibitors on peritoneal protein loss and solute transport in peritoneal dialysis patients
por: Basturk, Taner, et al.
Publicado: (2012)

Factors Associated with Long-Term Survival in Maintenance Hemodialysis Patients: A 5-Year Prospective Follow-Up Study
por: Ahbap, Elbis, et al.
Publicado: (2022)

Unexpectedly High Prevalence of Low Alpha-Galactosidase A Enzyme Activity in Patients with Focal Segmental Glomerulosclerosis
por: Hasbal, Nuri Baris, et al.
Publicado: (2020)

Pentraxin-2 is Associated with Renal Fibrosis in Patients Undergoing Renal Biopsy
por: Basturk, Taner, et al.
Publicado: (2020)

Aldosterone Resistance Due to Tacrolimus: A Case Report
por: Çağlayan, Feyza Bayraktar, et al.
Publicado: (2018)

Effects of human Umbilical Cord Stem Cells and Granulocyte Colony- Stimulating Factor (G-CSF) on Carbon Tetrachloride-Induced Nephrotoxicity
por: Koc, Yener, et al.
Publicado: (2012)

Comparison of lung ultrasound and other volumetric methods in peritoneal dialysis patients
por: Sevinc, Mustafa, et al.
Publicado: (2021)

Renal Damage Frequency in Patients with Solitary Kidney and Factors That Affect Progression
por: Basturk, T., et al.
Publicado: (2015)

Leukocytoclastic Vasculitis Associated with a New Anticoagulant: Rivaroxaban
por: Hasbal, Nuri Barış, et al.
Publicado: (2017)

Frequency of depressive symptoms in Syrian refugees and Turkish maintenance hemodialysis patients during COVID-19 pandemic
por: Sevinc, Mustafa, et al.
Publicado: (2021)

Comparison of Exit-Site Infection Frequency in Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis Patients: A Single-Center Experience
por: Sevinç, Mustafa, et al.
Publicado: (2019)

Membranoproliferative glomerulonephritis and a rare bleeding disorder: factor X deficiency
por: Basturk, T., et al.
Publicado: (2010)

Assessing the Impact of Prophylactic Eculizumab on Renal Graft Survival in Atypical Hemolytic Uremic Syndrome
por: Glover, Emily K., et al.
Publicado: (2023)

Does Residual Renal Function Have a Beneficial Effect on Patient and Technique Survival in Peritoneal Dialysis Patients?
por: Ahbap, Elbis, et al.
Publicado: (2018)

Atypical Hemolytic Uremic Syndrome
por: Kavanagh, David, et al.
Publicado: (2013)

Critical appraisal of eculizumab for atypical hemolytic uremic syndrome
por: Palma, Lilian M Pereira, et al.
Publicado: (2016)

Atypical hemolytic uremic syndrome and eculizumab therapy in children
por: Kim, Seong Heon, et al.
Publicado: (2018)

Treatment of Atypical Hemolytic-Uremic Syndrome in the Era of Eculizumab
por: Ebrahem, Rawaa, et al.
Publicado: (2017)

Neonatal Atypical Hemolytic Uremic Syndrome in the Eculizumab Era
por: Gomes, Sara Madureira, et al.
Publicado: (2021)

The Importance of Eculizumab in the Treatment of Atypical Hemolytic Uremic Syndrome
por: Santos, Mariana S, et al.
Publicado: (2022)

CFH-CFHR1 hybrid genes in two cases of atypical hemolytic uremic syndrome
por: Sugawara, Yuka, et al.
Publicado: (2023)

Eculizumab in Typical Hemolytic Uremic Syndrome (HUS) With Neurological Involvement
por: Pape, Lars, et al.
Publicado: (2016)

Should eculizumab be discontinued in patients with atypical hemolytic uremic syndrome?
por: Rodriguez, Eva, et al.
Publicado: (2017)

Utilization Pattern for Eculizumab Among Children With Hemolytic Uremic Syndrome
por: Ranabothu, Saritha, et al.
Publicado: (2021)

Eculizumab in the Treatment of Gemcitabine-Induced Atypical Hemolytic Uremic Syndrome
por: Azad, Farhan, et al.
Publicado: (2023)

Eculizumab in the Treatment of Acetylcysteine-Induced Atypical Hemolytic Uremic Syndrome
por: Jalbert, Arielle, et al.
Publicado: (2023)

The effects of the recommended dose of creatine monohydrate on kidney function
por: Taner, Basturk, et al.
Publicado: (2011)

Deleterious Impact of a Novel CFH Splice Site Variant in Atypical Hemolytic Uremic Syndrome
por: Schönauer, Ria, et al.
Publicado: (2019)

A Case of Atypical Hemolytic Uremic Syndrome Successfully Treated with Eculizumab
por: Thajudeen, B., et al.
Publicado: (2013)

Atypical Hemolytic Uremic Syndrome and Chronic Ulcerative Colitis Treated with Eculizumab
por: Webb, Tennille N., et al.
Publicado: (2015)

Atypical Hemolytic Uremic Syndrome Secondary to Lupus Nephritis, Responsive to Eculizumab
por: Raufi, Alexander G., et al.
Publicado: (2016)

Eculizumab, SARS-CoV-2 and atypical hemolytic uremic syndrome
por: Trimarchi, Hernán, et al.
Publicado: (2020)

Atypical Hemolytic Uremic Syndrome After Liver Transplant Treated With Eculizumab
por: Bhatti, Sundus, et al.
Publicado: (2020)

Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use
por: Wijnsma, Kioa L., et al.
Publicado: (2018)

189 Eculizumab Therapy for Gemcitabine-Induced Atypical Hemolytic Uremic Syndrome
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g1na02ef1q57a57q5pl1rfh2na